[S,S]-Reboxetine
[S,S]-Reboxetine is a pharmaceutical drug with 11 clinical trials. Historical success rate of 45.5%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
7
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
45.5%
5 of 11 finished
54.5%
6 ended early
0
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia
A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.
Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia
A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.
A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia
Clinical Trials (11)
Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia
A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.
Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia
A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.
A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia
[S,S]-Reboxetine Dose-Range Finding Trial
Evaluation of A Novel Methodology in the Assessment of Urethral Function Using [S,S]-Reboxetine in Healthy Volunteers
[S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.
A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.
[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.
Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11